Cannabis Publications
2024
- Kim C, Bai Y, Allin S, Kirst M, O’Campo P, Ienciu K, Xia X, MacMaster F, Rittenbach K, Chum A. (2024). Cannabis legalization and hospitalizations in Alberta: Interrupted time series analysis by age and sex. J Addict Dis. 2024 May 19:1-4.
- Dubois C, Fernandes H, Lin M, Martins KJB, Dyck JRB, Klarenbach SW, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2024). Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada. BMC Public Health. 24(1):859.
- Vieira JL, Snaychuk LA, Milicevic J, Hodgins DC, Shead NW, Keough MT, Kim HS. (2024). Adverse Childhood Experiences and Problematic Cannabis Use: The Role of Emotion Dysregulation and Affective Impulsivity. Cannabis. 6(4):111-126.
- Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A. (2024). Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophr Res. 264:534-542.
2023
- Soos B, Garies S, Cornect-Benoit A, Montgomery L, Sharpe H, Rittenbach K, Manca D, Duerksen K, Forst B, Drummond N. (2023). Documenting cannabis use in primary care: a descriptive cross-sectional study using electronic medical record data in Alberta, Canada. BMC Res Notes. 16(1):9.
- Kim C, Dusing GJ, Nielsen A, MacMaster FP, Rittenbach K, Allin S, O’Campo P, Penney TL, Hamilton HA, Kirst M, Chum A. (2023). Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada. Psychol Med. 53(15):7127-7137.
- Wiese JL, Watson TM, Owusu-Bempah A, Hyshka E, Wells S, Robinson M, Elton-Marshall T, Rueda S. (2023). Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada. Contemp Drug Probl. 50(1):25-45.
- Bahji A, Socias ME, Bach P, Milloy MJ. (2023). Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective. Cannabis Cannabinoid Res. 8(5):699-702.
- Elkrief L, Bastien G, McAnulty C, Bakouni H, Hébert FO, Socias ME, Le Foll B, Lim R, Ledjiar O, Marsan S, Brissette S, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. (2023). Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study. J Subst Use Addict Treat. 149:209031.
2022
- Andrews CN, Rehak R, Woo M, Walker I, Ma C, Forbes N, Rittenbach K, Hathaway J, Wilsack L, Liu A, Nasser Y, Sharkey KA. (2022). Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence. Aliment Pharmacol Ther. 56(11-12):1532-1542.
- Kim C, Chum A, Nielsen A, Allin S, Penney TL, Rittenbach K, MacMaster FP, O’Campo P. (2022). Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study. PLoS One. 17(10):e0268718.
- Kim C, Chum A, Nielsen A, MacMaster F, Rittenbach K, Allin S, O’Campo P, Kirst M, Hamilton H. (2022). Cannabis Legalization and cannabis-Related Hospitalizations in Ontario, Canada. Can J Psychiatry. 27:7067437221114785. doi: 10.1177/07067437221114785.
- Williamson N, Hathaway J, Jahrig J, Vik S, Rittenbach K. (2022). Cannabis use and concern among clients seeking substance misuse treatment: demographics, comorbidities, and service utilization patterns pre-legalization (2012-2018). Canadian Journal of Addiction. 13(1): 19-26.
2021
- Yeung MEM, Weaver CG, Hartmann R, Haines-Saah R, Lang E. (2021). Emergency Department Pediatric Visits in Alberta for Cannabis After Legalization. Pediatrics. 148(4):e2020045922.
- Haines-Saah RJ, Fischer B. (2021). Youth Cannabis use and Legalization in Canada – Reconsidering the Fears, Myths and Facts Three Years In. J Can Acad Child Adolesc Psychiatry. 30(3):191-196.
- Chayama KL, Valleriani J, Ng C, Haines-Saah R, Capler R, Milloy MJ, Small W, McNeil R. (2021). The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study. Drug Alcohol Rev. 40(7):1325-1333.
- Lee C, Voaklander D, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada. Inj Epidemiol. 8(1):33.
- BMC Public Health. 21(1):843.
- Harm Reduct J. 18(1):61.
- n JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada. Can J Psychiatry. 7067437211043393. doi: 10.1177/07067437211043393.
- BMC Cardiovasc Disord. 21(1):426.
- Can J Psychiatry. doi: 10.1177/07067437211060597.
- . (2021). Correlates of driving after cannabis use in high school students. Prev Med. 150:106667. doi: 10.1016/j.ypmed.2021.106667. Epub 2021 Jun 1.PMID: 34081937
Sep;150:106667. doi: 10.1016/j.ypmed.2021.106667. Epub 2021 Jun 1.PMID: 34081937 - Gibson, M., Williamson, L., Henwood, G., Chalmers, D., Dell, C.D. (2021). Perceptions and use of alcohol and medical cannabis among Canadian military veterans living with PTSD. Journal of Veterans Studies. 7(1), 59–70.
2020
- Yeung MEM, Weaver CG, Janz K, Haines-Saah R, Lang E. (2020). Clearing the air: A study of cannabis-related presentations to urban Alberta emergency departments following legalization. CJEM. 22(6):776-783.
- Valleriani J, Haines-Saah R, Capler R, Bluthenthal R, Socias ME, Milloy MJ, Kerr T, McNeil R. (2020). The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada. Int J Drug Policy. 79:102737.
- Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Cannabinoids for the neuropsychiatric symptoms of dementia: a systematic review and meta-analysis. Canadian Journal of Psychiatry. 65(6): 365-376.
- Bahji A, Chinna-Meyyappan A, Hawken E. (2020). Efficacy and acceptability of cannabinoids for anxiety disorders in adults: a systematic review & meta-analysis. Journal of Psychiatric Research. 129:257-264.
- Bahji A, Stephenson C, Tyo R, Hawken ER, Seitz D. (2020). Prevalence of cannabis withdrawal among regular or dependent users of cannabinoids: a systematic review and meta-analysis. Journal of the American Medical Association—Open Network. 3(4): 3095.
- Round JM, Lee C, Hanlon JG, Hyshka E, Dyck J, Eurich D. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20:987. DOI: 1186/s12889-020-09089-3.
2019
- Bahji A. (2019). Incidence and correlates of cannabinoid-related psychiatric emergency care: a retrospective, multi-year cohort study. Canadian Journal of Addiction. 11 (1), 14-18.
- Bahji A, Stephenson C. (2019). International perspectives on the implications of cannabis legalization: A systematic review & thematic analysis. International Journal of Environmental Research and Public Health. 16(17): 3095.
- Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2019). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. pii: jech-2019-212438.
- Jutras-Aswad, D., Le Foll, B., Bruneau, J., Wild, T.C., Wood, E., & Fischer, B. (2019). Thinking beyond legalization: The case for expanding evidence-based options for cannabis use disorder treatment in Canada. Canadian Journal of Psychiatry. 64(2), 82-87.
- Lee C, Voaklander D, Minhas-Sandhu JK, Dyck J, Hanlon JG, Hyshka E, Eurich DT. (2019). Cohort study of medical cannabis authorizations and motor vehicle accident-related healthcare visits in 2014-2017 in Ontario, Canada. Revision requested. Injury Prevention.
- Watson TM, Valleriani J, Hyshka E, Rueda S. (2019). Cannabis legalization in the provinces and territories: Missing opportunities to effectively educate youth? Canadian Journal of Public Health. 110(4), 472-475.
- Watson TM, Hyshka E, Bonato S, Rueda S. (2019). Early-stage cannabis regulatory policy planning across Canada’s four largest provinces: A descriptive overview. Substance Use & Misuse. 54(10), 1691-1704.
- Haines-Saah R. (2019). Cannabis and Mental Health: Insights from Canadian Research. Can J Psychiatry. 64(5):302-303.
- Haines-Saah RJ, Mitchell S, Slemon A, Jenkins EK. (2019). ‘Parents are the best prevention’? Troubling assumptions in cannabis policy and prevention discourses in the context of legalization in Canada. Int J Drug Policy. 68:132-138.
- Lake S, Kerr T, Werb D, Haines-Saah R, Fischer B, Thomas G, Walsh Z, Ware MA, Wood E, Milloy MJ. (2019). Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada. Drug Alcohol Rev. 38(6):606-621.
2018
- Bahji A, Scimeca M, Hurley B, Penders T, Stanciu C. (2018). A Case of Synthetic Cannabinoid Abuse: Summary of Case Conference from American Academy of Addictions Psychiatry 2017 Annual Meeting. American Journal on Addictions. 27: 265-272.
- Currie S., Flores-Pajot, M-C., Hodgins D. C., Nadeau, L., Paradis C., Robillard C., & Young M. (2018). A research plan to define Canada’s first Low-Risk Gambling Guidelines. Health Promotion Internationa. 34(6), 1207-1217.
- Hodgins, D.C., Stea, J.N. (2018). Insights from individuals successfully recovered from cannabis use disorder: Natural versus treatment-assisted recoveries and abstinent versus moderation outcomes. Addiction Science & Clinical Practice. 13(16), 1-9.
- Hodgins, D.C., & Stea, J. (2018). Psychometric evaluation of a lifetime version of the marijuana problems scale. Additive Behaviors Reports 8, 21-24.
- Mutti-Packer, S. , Collyer, B. & Hodgins, D. C. (2018). Perceptions of plain packaging and health waning labels for cannabis among young adults: Findings from an experimental study. BMC Public Health. 18(1).
- Haines-Saah RJ, Jenkins EK. (2018). Setting the Legal Age for Access to Cannabis in Canada: Bridging Neuroscience, Policy, and Prevention. Neuropsychopharmacology. 43(1):213-214.
2017
- Spackman E, Haines-Saah R, Danthurebandara VM, Dowsett LE, Noseworthy T, Clement FM. (2017). Marijuana Use and Perceptions of Risk and Harm: A Survey among Canadians in 2016. Healthc Policy. 13(1):17-27.
2016
- Bahji A, Mazhar MN. (2016). Treatment of Cannabis Dependence with Synthetic Cannabinoids: A Systematic Review. Canadian Journal of Addictions. 7(4):8-13.
- Kirst M, Kolar K, Chaiton M, Schwartz R, Emerson B, Hyshka E, Jesseman R, Lucas P, Solomon R, Thomas G. (2016). A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health. 106(8):e474-6.
2015
- Stea JN, Yakovenko I, Hodgins DC. (2015). Recovery from cannabis use disorders: Abstinence versus moderation and treatment-assisted recovery versus natural recovery. Psychol Addict Behav. 29(3),522-31.
2011
- Hyshka E, Erickson PG, Hathaway A. (2011). The time for marijuana decriminalization has come again . . . and again. Criminal Law Bulletin. 47(2):258-275.
- Stea JN, Hodgins DC, Lambert MJ. (2011). Relations between delay discounting and low to moderate gambling, cannabis, and alcohol problems among university students. Behav Processes. 88(3):202-5.
2010
- Erickson PG, Hyshka E. (2010). Four decades of cannabis criminals in Canada 1970-2010. Amsterdam Law Forum. 2(4):14.
- Hathaway A, Hyshka E, Erickson PG, Asbridge M, Brochu S, Cousineau MM, Duff C, Marsh D. (2010). Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduction Journal. 7:15.
2009
- Hyshka E. (2009). The Saga Continues: Canadian Legislative Attempts to Reform Cannabis Law in the Twenty-First Century. Canadian Journal of Criminology and Criminal Justice. 51(1), 73–91.
- Hyshka, E. (2009). Turning failure into success: what does the case of Western Australia tell us about Canadian cannabis policy-making? Policy Studies. 30(5), 513–531.
